Please log in to determine if you are eligible to purchase PT Programs.
NEXT-GENERATION SEQUENCING - GERMLINE - NGS
NGS
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
All laboratories subject to US Clinical Laboratory Improvement Amendments (CLIA) Regulations: Proficiency testing (PT) challenges must NOT be referred to another laboratory for any portion of NGS testing, even if this is how patient testing is routinely performed. For PT challenges, any referral is strictly prohibited by CMS.


Procedure Challenges per Shipment Number of Shipments
Next-generation sequencing 2 Two shipments per year

Additional Information

  • Laboratories will have the ability to analyze up to 200 preselected chromosomal positions within various genes; for the full list of genes in this program, click here.

Program Information

  • One 10.0‑µg extracted DNA specimen; one educational variant interpretation paper challenge
  • Methods-based challenge for germline variants for laboratories using gene panels, exome, and whole genome sequencing
  • Results for this program must be submitted online through e-LAB Solutions Suite

Shipping Schedule

  • Shipment A: March 2
  • Shipment B: September 14






Customers Who Bought This Item Also Bought
Developing and Organizing an Institutional Biospecimen Repository
VIEW DETAILS >
NGS UNDIAGNOSED DISORDERS-EXOME
VIEW DETAILS >
NON-INVASIVE PRENATAL TESTING
VIEW DETAILS >
NGS BIOINFORMATICS SOMATIC VALIDATED MATERIAL
VIEW DETAILS >
FUSION RNA SEQUENCING
VIEW DETAILS >
VARIANT INTERPRETATION ONLY
VIEW DETAILS >